Bydureon bcise and Dexilant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bydureon bcise (exenatide) and Dexilant (dexlansoprazole). Common drug interactions include injection site extravasation among females and injection site nodule among males.

The phase IV clinical study analyzes what interactions people have when they take Bydureon bcise and Dexilant. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Bydureon bcise?

Bydureon bcise has active ingredients of exenatide. eHealthMe is studying from 13,812 Bydureon bcise users. Check the latest studies of Bydureon bcise.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.

On Jul, 14, 2026

18 people who take Bydureon bcise and Dexilant together, and have interactions are studied.

Bydureon bcise and Dexilant drug interactions.

What are the common drug interactions of Bydureon Bcise and Dexilant, by gender? *:

female:

Injection site extravasation (flow of (blood or lymph) from injection site)
Injection site mass
Weight decreased
Angina pectoris (chest pain due to ischemia of the heart muscle)
Hunger
Hypersomnia (excessive daytime sleepiness (eds))
Injection site pruritus (severe itching at injection site)
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)

male:

Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Diarrhoea
Erythema (redness of the skin)
Injection site pain
Injection site swelling
Tenderness (pain or discomfort when an affected area is touched)
Weight decreased

What are the common drug interactions of Bydureon Bcise and Dexilant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Hunger
Hypersomnia (excessive daytime sleepiness (eds))
Injection site extravasation (flow of (blood or lymph) from injection site)
Injection site pruritus (severe itching at injection site)
Migraine (headache)
Nausea (feeling of having an urge to vomit)

50-59:

n/a

60+:

Injection site erythema (redness at injection site)
Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Hepatic steatosis (fatty liver disease)
Injection site pain
Weight decreased
Anxiety
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood pressure decreased

What are the existing conditions these people have? *

Type 2 Diabetes: 14 people, 77.78%
High Blood Cholesterol: 7 people, 38.89%
Abdominal Discomfort: 6 people, 33.33%
Depression: 4 people, 22.22%
High Blood Pressure: 4 people, 22.22%
Ill-Defined Disorder: 3 people, 16.67%
Blood Pressure Abnormal: 3 people, 16.67%
Anaemia (lack of blood): 2 people, 11.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
Blood Glucose Increased: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon bcise and Dexilant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously